Bioline Rx Ltd - ADR

XNAS:BLRX

3.38

+0.12 (+3.78%)

4:10:04 PM EDT: $3.36 -0.02 (-0.59%)

Market Cap (Intraday)	15.26M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.51 Million
Adjusted EPS	-$0.39

See more estimates

10-Day MA	$3.34
50-Day MA	$3.62
200-Day MA	$3.72

See more pivots

Bioline Rx Ltd - ADR Stock, XNAS:BLRX

Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in, HaMerkaz 7177871

Israel

Phone: +972.8.642.9100

Number of Employees: 38

http://www.biolinerx.com

Description

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.